LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 13, n. 1, p. e2021065, 2021. DOI: 10.4084/MJHID.2021.065. Disponível em: https://www.mjhid.org/mjhid/article/view/4720. Acesso em: 6 jun. 2026.